Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RNAx
Berlin, Berlin, Germany
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
RNAx is a biotechnology company based in Berlin, Germany, specializing in RNA interference (RNAi) technologies and therapeutic development. Founded in 2003 as a spin-off from Atugen (now Silence Therapeutics), the company provides specialized services and expertise in the design, synthesis, and validation of small interfering RNAs (siRNAs). RNAx offers a proprietary platform for siRNA optimization and conducts contract research for pharmaceutical and biotechnology partners to identify and validate novel therapeutic targets. Their work primarily supports drug discovery efforts in oncology and inflammatory diseases through high-throughput screening and functional genomics.
- Therapeutic areas
- OncologyImmunology
- Modalities
- RNA therapySmall interfering RNAAntisense oligonucleotide
- Industry
- Drug Discovery Services
02
Partnerships
Silence TherapeuticsMax Planck Institute
Beyond the preview
Go deeper on RNAx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNAx.